Results 121 to 130 of about 18,145 (196)

Risk of intraocular hemorrhage among exudative age-related macular degeneration patients treated with different anti-VEGF agents. [PDF]

PLoS One
Kim MS, Nam S, Lee J, Woo SJ.
europepmc   +1 more source

Differential efficacy of Conbercept vs. Ranibizumab on retinal microstructural changes in macular edema secondary to retinal vein occlusion during the loading phase. [PDF]

Front Med (Lausanne)
Yu H, Yao Z, Teng J, Zhang Q, Liu T, Zhu G.   +5 more
europepmc   +1 more source

Optical Coherence Tomography Biomarkers in Diabetic Macular Edema and Their Role in Predicting Visual Outcome After Ranibizumab or Triamcinolone Injection. [PDF]

Cureus
Palanisamy S, Mishra P, Nayak B, Moharana B, Panda BB, Parija S, Ramasubbu MK.   +6 more
europepmc   +1 more source

Direct randomized evidence comparing ranibizumab and bevacizumab for macular edema secondary to retinal vein occlusion: a systematic review and meta-analysis. [PDF]

BMC Ophthalmol
Liang Y, Deng X, Chen M, Zhang X.
europepmc   +1 more source

Combination verteporfin photodynamic therapy ranibizumab-dexamethasone in choroidal neovascularization due to age-related macular degeneration: results of a phase II randomized trial

, 2017
Ron P Gallemore,1 Josh Wallsh,1 Henry L Hudson,2 Allen C Ho,3 Richard Chace,4 Joel Pearlman5 On behalf of the RADICAL Trial Group 1Retina Macula Institute, Torrance, CA, 2Retina Centers PC, Tucson, AZ, 3Wills Eye Institute, Philadelphia, PA, 4Eyesight
Ho AC, Hudson HL, Pearlman J, Wallsh J, Gallemore RP, Chace R   +5 more
core  

Disproportionality analysis of off-label intravitreal bevacizumab in the FDA Adverse Event Reporting System database. [PDF]

Ther Adv Drug Saf
Contreras-Salinas H, Vázquez-Beltrán JC, García-Sánchez G, Quirarte-Justo S, Gómez-Macías SDC, Rodríguez-Herrera LY.   +5 more
europepmc   +1 more source

The effects of ranibizumab injections on fluorescein angiographic findings and visual acuity recovery in age-related macular degeneration

, 2014
Hulya Gungel,1 Ozen Ayranci Osmanbasoglu,1 Cigdem Altan,2 Deniz Oygar Baylancicek,3 Isil Basgil Pasaoglu2 1Istanbul Education and Research Hospital, Eye Clinic, 2Beyoglu Eye Education and Research Hospital, 3Kudret Eye Hospital, Istanbul, Turkey Aim ...
Baylancicek DO, Pasaoglu IB, Osmanbasoglu OA, Altan C, Gungel H   +4 more
core  

Nano-drops of biomimetic macromolecular drugs based on macrophage membranes for targeted treatment of fundus diseases. [PDF]

Mater Today Bio
Xiang Y, Kou J, Cao H, Zhang Y, Cheng H, Wang T, Jiang J, Pan S, Kang J, Ding Y, Wan W, Zheng S, Li M, Huang X, Hu K.   +14 more
europepmc   +1 more source

Two-year outcomes of pro re nata ranibizumab monotherapy for exudative age-related macular degeneration in Japanese patients

, 2013
Akiko Yamamoto,1 Annabelle A Okada,1 Atsuhiko Sugitani,1,2 Daisuke Kunita,1 Tosho Rii,1 Reiji Yokota1 1Department of Ophthalmology, Kyorin University School of Medicine, Tokyo, Japan; 2Department of Ophthalmology, Kugayama Hospital, Tokyo, Japan Purpose:
Kunita D, Rii T, Okada AA, Sugitani A, Yokota R, Yamamoto A   +5 more
core  

Comparison of conbercept and ranibizumab for the treatment of idiopathic choroidal neovascularization using optical coherence tomography angiography and multifocal electroretinography. [PDF]

Front Pharmacol
Zhai G, Zhu L, Su Y, Wang Z.
europepmc   +1 more source